Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyNet Income towards Common StockholdersOperating IncomePreferred Dividend PaymentsProfit After TaxRevenueShares Outstanding (Weighted Average)
Others
Ratios

cbdMD (YCBD) Shares Outstanding (Weighted Average): 2017-2025

Historic Shares Outstanding (Weighted Average) for cbdMD (YCBD) over the last 8 years, with Sep 2025 value amounting to $8.9 million.

  • cbdMD's Shares Outstanding (Weighted Average) rose 1794.64% to $8.9 million in Q3 2025 from the same period last year, while for Sep 2025 it was $8.9 million, marking a year-over-year increase of 1794.64%. This contributed to the annual value of $8.9 million for FY2025, which is 1794.64% up from last year.
  • Per cbdMD's latest filing, its Shares Outstanding (Weighted Average) stood at $8.9 million for Q3 2025, which was up 0.05% from $8.9 million recorded in Q2 2025.
  • In the past 5 years, cbdMD's Shares Outstanding (Weighted Average) registered a high of $8.9 million during Q3 2025, and its lowest value of $145,241 during Q1 2021.
  • For the 3-year period, cbdMD's Shares Outstanding (Weighted Average) averaged around $2.0 million, with its median value being $483,635 (2024).
  • Data for cbdMD's Shares Outstanding (Weighted Average) shows a peak YoY soared of 1,794.64% (in 2025) over the last 5 years.
  • Over the past 5 years, cbdMD's Shares Outstanding (Weighted Average) (Quarterly) stood at $160,568 in 2021, then climbed by 4.98% to $168,560 in 2022, then skyrocketed by 119.58% to $370,118 in 2023, then soared by 87.07% to $692,390 in 2024, then spiked by 1,794.64% to $8.9 million in 2025.
  • Its Shares Outstanding (Weighted Average) stands at $8.9 million for Q3 2025, versus $8.9 million for Q2 2025 and $782,854 for Q1 2025.